SRNE · Categories · Form 4

SRNE - SEC Form 4 insider transactions

Sorrento Therapeutics Inc. (SRNE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SRNE

• 1172d
  SEC Form 4 filed by Sorrento Therapeutics Inc.

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1259d
  SEC Form 4: Ji Henry exercised 500 in-the-money shares at a strike of $5.50

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1266d
  SEC Form 4: Ji Henry was granted 1,500,000 shares, increasing direct ownership by 31% to 6,265,805 units

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1366d
  SEC Form 4: Ji Henry bought $179,349 worth of shares (88,888 units at $2.02), increasing direct ownership by 2% to 4,765,805 units

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1367d
  SEC Form 4: Ji Henry bought $108,882 worth of shares (55,555 units at $1.96), increasing direct ownership by 1% to 4,676,917 units

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1371d
  SEC Form 4: Ji Henry was granted 2,500,000 shares, increasing direct ownership by 118% to 4,621,362 units

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1378d
  SEC Form 4: Ji Henry bought $70,333 worth of shares (33,333 units at $2.11), increasing direct ownership by 2% to 2,121,362 units

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1379d
  SEC Form 4: Ji Henry bought $45,768 worth of shares (22,222 units at $2.06), increasing direct ownership by 1% to 2,088,029 units

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1451d
  SEC Form 4: Ji Henry bought $13,999 worth of shares (10,000 units at $1.40), increasing direct ownership by 0.49% to 2,065,807 units

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1476d
  SEC Form 4 filed by Czerepak Elizabeth

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1476d
  SEC Form 4 filed by Reilly Tammy

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1620d
  SEC Form 4: Janda Kim exercised 3,000 shares at a strike of $4.00 and sold $17,640 worth of shares (3,000 units at $5.88) as part of a pre-agreed trading plan

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1659d
  SEC Form 4 filed by Czerepak Elizabeth

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1709d
  SEC Form 4: Ji Henry exercised 10,000 shares at a strike of $4.00, increasing direct ownership by 0.49% to 2,055,807 units

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1710d
  SEC Form 4: Janda Kim exercised 42,357 shares at a strike of $2.11 and sold $339,720 worth of shares (42,357 units at $8.02) as part of a pre-agreed trading plan

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1724d
  SEC Form 4: Janda Kim sold $64,285 worth of Common Stock (8,000 units at $8.04) and exercised 8,000 units of Common Stock at a strike of $3.50

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1735d
  SEC Form 4: Smith Robin L exercised 175,000 units of Common Stock at a strike of $4.49, increasing direct ownership by 292% to 235,000 units

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1739d
  SEC Form 4 filed by Ji Henry

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1739d
  SEC Form 4 filed by Wu Yue Alexander

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1739d
  SEC Form 4 filed by Smith Robin L

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1739d
  SEC Form 4 filed by Shah Jaisim

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1739d
  SEC Form 4 filed by Lemus David

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1739d
  SEC Form 4 filed by Janda Kim

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1739d
  SEC Form 4 filed by Followwill Dorman

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1876d
  SEC Form 4: Janda Kim exercised 1,900 units of Common Stock at a strike of $3.50 and sold $13,251 worth of Common Stock (1,900 units at $6.97)

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1905d
  SEC Form 4: Najjam Asghar was granted 56,974 units of Common Stock

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)
• 1955d
  SEC Form 4: Dorman Followwill transfered by will 1,000 units of Common Stock) and sold $7,135 worth of Common Stock (1,000 units at $7.13)

  4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)

Other SRNE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends